The registration, importation and distribution of all heartburn medication containing ranitidine has been suspended in the UAE.
According to the Ministry of Health and Prevention (MoHAP), a circular was issued to health facilities and practitioners informing them about the move.
The decision is based on the recommendations of the US Food and Drug Administration (FDA) and other regulatory bodies regarding a possible contamination of the medicine with an impurity which is classified as potentially carcinogenic.
The Ministry says those wishing to stop taking medicine with ranitidine should consult a healthcare professional for a replacement.

H.H. Sheikh Mohammed discusses ties with Ecuador President
UAE President meets Seychelles President ahead of F1 GP
RTA installs 595 bus shelters in key areas across Dubai
H.H. Sheikh Mohammed meets with African business, philanthropic leaders
Zayed bin Hamdan meets Azerbaijan’s Minister of Economy
